
ACADIA Pharmaceuticals (NASDAQ:ACAD) brought in sales totaling $115.47 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 162.35%, resulting in a loss of $113.06 million. ACADIA Pharmaceuticals collected $130.76 million in revenue during Q4, but reported earnings showed a $43.09 million loss.